Affordable Access

deepdyve-link deepdyve-link
Publisher Website

The role of immunophilin ligands in nerve regeneration.

Authors
  • Toll, Edward C
  • Seifalian, Alexander M
  • Birchall, Martin A
Type
Published Article
Journal
Regenerative medicine
Publication Date
Sep 01, 2011
Volume
6
Issue
5
Pages
635–652
Identifiers
DOI: 10.2217/rme.11.43
PMID: 21916598
Source
Medline
License
Unknown

Abstract

Tacrolimus (FK506) is a widely used immunosuppressant in organ transplantation. However, it also has neurotrophic activity that occurs independently of its immunosuppressive effects. Other neurotrophic immunophilin ligands that do not exhibit immunosuppression have subsequently been developed and studied in various models of nerve injury. This article reviews the literature on the use of tacrolimus and other immunophilin ligands in peripheral nerve, cranial nerve and spinal cord injuries. The most convincing evidence of enhanced nerve regeneration is seen with systemic administration of tacrolimus in peripheral nerve injury, although clinical use is limited due to its immunosuppressive side effects. Local tacrolimus delivery to the site of nerve repair in peripheral and cranial nerve injury is less effective but requires further investigation. Tacrolimus can enhance outcomes in nerve allograft reconstruction and accelerates reinnervation of complex functional allograft transplants. Other non-immunosuppressive immunophilins ligands such as V-10367 and FK1706 demonstrate enhanced neuroregeneration in the peripheral nervous system and CNS. Mixed results are found in the application of immunophilin ligands to treat spinal cord injury. Immunophilin ligands have great potential in the treatment of nerve injury, but further preclinical studies are necessary to permit translation into clinical trials.

Report this publication

Statistics

Seen <100 times